drugset / Trial / NCT00502775
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of the study is to compare nighttime symptom relief of fluticasone furoate nasal spray versus oral fexofenadine
Timeline
- Start
- 2007-08
- Primary completion
- 2007-11
- Completion
- 2007-11
Outcome
Met primary endpoint
registry analysis (superiority or other test); Fluticasone Furoate 110mcg vs Fexofenadine 180 mg; p <0.001; Mean Difference (Net) -0.9 (95% CI -1.2 to -0.6); ANCOVA NCT00502775 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fexofenadine | Unknown | — | Oral |
| Subject | Fluticasone Furoate | Other / unclassified | — | Intranasal |